Evaluating the accuracy of home lactate meters in patients with Glycogen Storage Disease Type Ia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the accuracy of home lactate meters, both capillary and serum samples, in patients diagnosed with Glycogen Storage Disease Type Ia. It will compare the readings from these home devices to lab serum lactate measurements to determine if they are within 20% accuracy 95% of the time. Additionally, the study will evaluate the accuracy of the Accu Chek Guide glucometer for capillary blood glucose readings against lab serum glucose levels in the same patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia (ICD 10 code: E74.01).
* Connecticut Children's Emergency Department visit and/or admission to Connecticut Children's during time study is active
* For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
* For adults: Ability to understand and the willingness to sign a written informed consent

Exclusion Criteria:

* Patients with Glycogen storage disease unspecified 74.00, or Ib
* Patients not meeting inclusion criteria

Where it's running

• Connecticut Children's Medical Center
  Hartford, Connecticut, United States Recruiting

Study contacts

• Study coordinator: Malaya Mount, MS, RD
• Email: mmount@connecticutchildrens.org
• Phone: 860-837-6700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home lactate and Accu‑Chek glucose meter accuracy for people with glycogen storage disease

  This project will see if a handheld Lactate Plus meter and an Accu‑Chek glucometer give results that match lab blood tests in people with glycogen storage disease types Ia, Ib, and XI.

  Recruiting Connecticut Children's Medical Center · Hartford, Connecticut · NCT07459582

• Evaluating BEAM-301 for treating Glycogen Storage Disease Type Ia

  This study is testing a new treatment called BEAM-301 to see if it is safe and effective for adults with Glycogen Storage Disease Type Ia who have a specific genetic variant.

  Recruiting at 3 sites Phase 1/2 Beam Therapeutics Inc. · Orange, California and 2 other locations · NCT06735755

• Monitoring program for patients with Glycogen Storage Disease Type Ia

  This study is tracking the long-term health and safety of a treatment called DTX401 in people with Glycogen Storage Disease Type Ia to see how it helps them over at least 10 years.

  Recruiting at 17 sites Ultragenyx Pharmaceutical Inc · Orange, California and 18 other locations · NCT06636383

• Glycogen Storage Disease and Brain Function in People Like You

  This study tests whether people with glycogen storage disease perform differently on cognitive tests and show different brain imaging features compared with healthy peers.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07908212

• Using advanced heart MRI to improve diagnosis and risk prediction for rare cardiomyopathies

  This project tests whether advanced cardiac MRI techniques can help diagnose and predict future risk for people with rare heart muscle diseases like Danon, Fabry, cardiac amyloidosis, Noonan syndrome, and cardiac sarcoidosis.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07336394

• Identifying patients with cardiomyopathy for potential heart transplantation

  This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Emilia-Romagna/Bologna and 2 other locations · NCT06813443

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.